Cost-Effectiveness Comparison Analysis of Semi-Markov Chain and Survival Analysis Models in Stage III Colon Cancer
IPS Journal of Physical Sciences · 2026
DOI: 10.54117/ijps.v3i2.45 ↗Kurz gefasst
Fachartikel in der Zeitschrift IPS Journal of Physical Sciences, 2026. Verfasst von Michael Aloysius Matthew und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A comparative analysis of the inferential capacity related to the semi-Markov chain and the survival analysis methodologies has been established through the identification of techniques that yield the best health benefits for stage III colon cancer. This study aims to evaluate the cost-effectiveness of a Semi-Markov decision model against survival analysis to evaluate the disease treatment and healthcare costs consideration of stage III colon cancer patients. The multi-stage transition probabilities, Kaplan Meier and Log rank estimates are calculated for the semi-Markov chain and Survival analysis respectively. Understanding the natural history of progressive diseases is essential for developing effective treatment strategies, allocating resources, and improving patient outcomes. In this context, cost-effectiveness analysis (CEA) has been carried out for the two approaches, which is essential for assessing the value of treatment interventions, balancing clinical benefits with economic considerations. The result recorded an estimated Incremental Cost-Effectiveness Ratio (ICER) of $10275 per Quality-Adjusted Life Year (QALY) gained, which indicates that $10275 per year is required to restore a patient’s life to perfect health, compared to the traditional benchmark of the US threshold ($50,000–$150,000) per QALY. The results of analysis show that the semi-Markov chain cost function is more efficient than that of survival analysis. In addition, the results of this study have been able to generate useful information that will help decision-making in improving patient care, health outcomes, and treatment costs as the ultimate objective and the pathway in identifying the most effective technique for examining the course of illness.
Zitieren
APA
Matthew, M. A., Iseh, M. J., & Ekaide, E. T. (2026). Cost-Effectiveness Comparison Analysis of Semi-Markov Chain and Survival Analysis Models in Stage III Colon Cancer. IPS Journal of Physical Sciences. https://doi.org/10.54117/ijps.v3i2.45
Vancouver
Matthew MA, Iseh MJ, Ekaide ET. Cost-Effectiveness Comparison Analysis of Semi-Markov Chain and Survival Analysis Models in Stage III Colon Cancer. IPS Journal of Physical Sciences. 2026. doi:10.54117/ijps.v3i2.45
BibTeX
@article{Matthew2026,
author = {Matthew, Michael Aloysius and Iseh, Matthew Joshua and Ekaide, Edikan Thomas},
title = {Cost-Effectiveness Comparison Analysis of Semi-Markov Chain and Survival Analysis Models in Stage III Colon Cancer},
journal = {IPS Journal of Physical Sciences},
year = {2026},
doi = {10.54117/ijps.v3i2.45}
}
EUVIMED